Form 8-K - Current report:
SEC Accession No. 0001193125-13-338085
Filing Date
2013-08-16
Accepted
2013-08-16 14:32:37
Documents
7
Period of Report
2013-08-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.06: Change in Shell Company Status
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d584597d8k.htm 8-K 459278
2 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION d584597dex21.htm EX-2.1 46394
3 ARTICLES OF INCORPORATION d584597dex31.htm EX-3.1 26899
4 BYLAWS d584597dex32.htm EX-3.2 98699
5 CERTIFICATE OF DESIGNATION d584597dex33.htm EX-3.3 37278
6 CERTIFICATE OF OWNERSHIP AND MERGER d584597dex34.htm EX-3.4 8465
7 CONTRIBUTION AGREEMENT d584597dex101.htm EX-10.1 60582
  Complete submission text file 0001193125-13-338085.txt   739437
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13467 | Film No.: 131044888
SIC: 8731 Services-Commercial Physical & Biological Research